Profile for Mexico Patent: 2012005769

US Patent Family Members and Approved Drugs for Mexico Patent: 2012005769

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
9,352,041	Nov 24, 2030	Chiesi	FILSUVEZ	birch triterpenes
9,827,214	Nov 24, 2030	Chiesi	FILSUVEZ	birch triterpenes

Key insights for pharmaceutical patentability - Mexico patent MX2012005769

Last updated: April 30, 2026

What is the patent scope and claims landscape for Mexico drug patent MX2012005769?

What does MX2012005769 cover?

No complete, authoritative record of Mexico patent MX2012005769 (title, assignee, publication number, priority, and claim set) is available in the provided information set, so a precise scope and claims analysis cannot be produced without risking factual errors.

What are the claim themes and how broad are they?

A claim-by-claim scope map requires the actual granted or published Mexico claim text (or the corresponding WO/EP/US application claims that Mexico entered). Without the claim set, any description of claim themes (compound, formulation, use, method, process, polymorph, salts, combinations) would be speculative.

How does MX2012005769 fit into the Mexico patent landscape?

Landscape analysis depends on at least:

• the publication family (WO/EP/US/CN) and whether Mexico granted claims match the family
• related continuation/divisional filings in Mexico
• the status of related patents in Mexico for the same active ingredient (including process, salt, polymorph, and dosage forms)
• any regulatory linkage data for Mexico (where applicable)

None of these inputs are available for MX2012005769 in the information set, so a defensible landscape cannot be constructed.

What is the actionable outcome for freedom-to-operate and enforcement?

A usable FTO and enforcement view requires:

• the exact claim scope (independent claims plus dependent fallback coverage)
• key exclusions/limitations in Mexico claims (e.g., specific substituents, ratios, stability conditions, dosing ranges, particle sizes)
• territorial validity in Mexico (status, maintenance, expiry)
• competitor patents and overlaps in Mexico

With no claim text or legal status, any actionable outcome would be unreliable.

---

Key Takeaways

• A complete scope and claims analysis for MX2012005769 cannot be produced without the patent’s actual Mexico claim text and bibliographic record.
• A Mexico-specific patent landscape (overlap, expiries, enforcement posture, and FTO impact) also cannot be produced without the family link and legal status.

---

FAQs

1. Can you summarize MX2012005769’s invention without the claims?
   No, the scope depends on the exact independent and dependent claim language.

2. Can you infer claim breadth from the title only?
   No. Titles do not determine legal scope.

3. Does Mexico always match the WO or US claims?
   Not necessarily; claim sets can change during prosecution, so matching requires the specific Mexico publication/grant record.

4. Can landscape mapping be done from the patent number alone?
   Not safely. Landscape mapping requires bibliographic details, family, and status.

5. What would be the next step to complete this analysis?
   Acquire the Mexico publication/grant record and full claim text for MX2012005769, then map to the family and Mexican legal status.

---

References

[1] No cited sources are available because MX2012005769 bibliographic and claim data were not provided in the prompt.